Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2273956 | 1.00 | ATM (0.59) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL9495093 | 1.00 | ATM (0.59) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL5612333 | 0.93 | TSHR (0.58) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL5612339 | 0.93 | TSHR (0.58) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL9313916 | 0.93 | TSHR (0.58) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL8169063 | 0.93 | TSHR (0.58) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL8383264 | 0.93 | TSHR (0.58) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL29109721 | 0.89 | ATM (0.55) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL20530243 | 0.88 | HCAR2 (0.48) | ATMTSHRHPGDALDH1A1HCAR2 | |
| SCHEMBL29374091 | 0.88 | HCAR2 (0.48) | ATMTSHRHPGDALDH1A1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122085625-A | Two-component developer | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260133517-A1 | TONER | CANON KK (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-4448615-B1 | COATING COMPOSITION | ALLNEX AUSTRIA GMBH (AT) | 2026-02-11 | — | — | EP | disclosed |
| EP-4289887-B1 | METHOD FOR PRODUCING RESIN COMPOSITION | ASAHI CHEMICAL IND (JP) | 2026-01-14 | — | — | EP | disclosed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | disclosed |
| US-20250353974-A1 | Method for Producing Resin Composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12466907-B2 | Acrylic rubber composition and rubber crosslinked product | ZEON CORPORATION (JP) | 2025-11-11 | — | — | US | disclosed |
| EP-4584243-B1 | CROSSLINKERS | HEMOTEQ AG (DE) | 2025-11-05 | — | — | EP | disclosed |
| US-20250314984-A1 | TONER AND METHOD OF PRODUCING TONER | CANON KK (JP) | 2025-10-09 | — | — | US | disclosed |
| US-5504272-A | DEVELOPING LATENT IMAGE UNDER ASYMMETIRC DEVELOPING BIAS VOLTAGE; QUALITY, STABILITY | CANON KABUSHIKI KAISHA (JP) | 1996-04-02 | — | — | US | disclosed |
| US-5480755-A | ELECTROGRAPHY, DEVELOPERS, SILICA TREATED WITH HEXAMETHYLDISILAZANE, METAL COMPLEX CHARGE CONTROL AGENTS | CANON KABUSHIKI KAISHA (JP) | 1996-01-02 | — | — | US | disclosed |
| US-5338894-A | Electrophotographic dry development process comprising coating a magnetic toner layer having iron oxide powder and binder, applying a bias voltage having direct current and asymmetric alternating current | CANON KABUSHIKI KAISHA (JP) | 1994-08-16 | — | — | US | disclosed |
| EP-0267506-B1 | ABS MOULDINGS WITH A REDUCED RESIDUAL BUTADIENE CONTENT | BAYER AG (DE) | 1993-03-17 | — | — | EP | disclosed |
| EP-0303704-B1 | PROCESS FOR POLYMERIZING ALPHA-OLEFIN | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1992-12-23 | — | — | EP | disclosed |
| EP-0503861-A1 | Magnetic toner, image forming method, surface-modified fine silica powder and process for its production | CANON KABUSHIKI KAISHA (JP) | 1992-09-16 | — | — | EP | disclosed |
| EP-0303704-A1 | PROCESS FOR POLYMERIZING ALPHA-OLEFIN | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-02-22 | — | — | EP | disclosed |
| US-4800216-A | ACRYLONITRILE-BUTADIENE-STYRENE | BAYER AKTIENGESELLSCHAFT (DE) | 1989-01-24 | — | — | US | disclosed |
| EP-0267506-A2 | ABS mouldings with a reduced residual butadiene content | BAYER AG (DE) | 1988-05-18 | — | — | EP | disclosed |
| US-4089860-A | Preparation of hydantoins by reacting esters of ethylene-1,2-dicarboxylic acids and ureas and thioureas | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260133517-A1 | TONER | DECR2, DECR1, TECR | ATM 4190/4885TSHR 1247/4885HPGD 3663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.